Established · publishing since 1996Rising activity
Salivary Gland Tumors Diagnosis and TreatmentCancer Cells and MetastasisNeuroblastoma Research and TreatmentsAngiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism
Publications
81
Citations
2,396
Est. group size
~4
Recurring co-author estimate
Active years
31
Publishing since 1996
In context
Among 4,953 established Medicine PIs within our index
Citations: 2,396p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 7.0p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 10 venues
Publication cadence
Publications per year over the last 10 years — averaging 7.0/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial
Nature Communications · 2026
- Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication
Pathology - Research and Practice · 2024
- Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma
Oral Oncology · 2023
- Supplementary Methods + Figures from Therapeutic Inhibition of the MDM2–p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas
2023
- Supplemental figures + legends from 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Data from Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
2023
- Supplemental figures + legends from 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure from p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness
2023
- Data from Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
2023
- Data from 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma
2023
- Data from Therapeutic Inhibition of the MDM2–p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas
2023
- Data from p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness
2023
- Data from Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
2023
- Data from 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma
2023
- Data from Therapeutic Inhibition of the MDM2–p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas
2023
Publishes in
- Clinical Cancer Research×5
- Oncotarget×4
- Cell Death and Disease×2
- Oral Oncology×2
- Oral Surgery Oral Medicine Oral Pathology and Oral Radiology×2
Similar researchers
By research-topic overlap
- Zhaocheng Zhang
Medicine · University of Michigan
- Felipe Nör
Medicine · University of Michigan
- Joseph I. Helman
Medicine · University of Michigan
- Carolina Emerick
Medicine · University of Michigan
- Chunjie Li
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile